Assessing Arxis (ARXS) Valuation After A Volatile Stretch In Share Price Momentum
Arxis, Inc. Class A ARXS | 0.00 |
Recent move in Arxis stock
Arxis (ARXS) drew investor attention after a one day share price decline of 4.1%, following a strong 29.1% gain over the past week and a 27.9% rise over the past month.
At a latest share price of $44.93, Arxis has combined a strong 7 day share price return of 29.1% with a 15.9% year to date share price gain. This suggests that momentum has recently strengthened after earlier periods of softer performance.
If this kind of sharp move has you looking around the market, it could be a good moment to widen the search and check out 20 top founder-led companies
After such a quick run in the share price, and with Arxis trading around an 8% gap to analyst targets but at a premium to some intrinsic estimates, you have to ask: is there still a buying opportunity here, or is the market already pricing in future growth?
Price-to-Sales of 11.6x: Is it justified?
On current numbers, Arxis carries a P/S ratio of 11.6x, which looks rich next to peers and the broader US Aerospace and Defense industry, even after the recent share price pullback.
The P/S multiple compares the company’s market value to its revenue and is often used when earnings are still bedding in. For Arxis, this is relevant because the company has only recently moved into profitability, and reported revenue of $1.59b versus net income of $46.0m.
Analysts are forecasting earnings growth of 32.5% per year and revenue growth of 9.1% per year. The SWS DCF model currently estimates future cash flow value at $32.06 per share, which is below the last close of $44.93. Together, these figures indicate that the current P/S level is reflecting strong profit expansion on top of the revenue outlook, even though the company’s Return on Equity is 1.5% and interest payments are not well covered by earnings.
Compared to a peer average P/S of 4.8x and a US Aerospace and Defense industry average of 5.2x, Arxis trades at more than double those reference points. This represents a clear premium that assumes the forecasts and profitability progression will hold up.
Result: Price-to-Sales of 11.6x (OVERVALUED)
However, if growth in the core US$1.59b revenue base slows, or recent net income trends reverse, the current premium P/S multiple could quickly look vulnerable.
Another view: DCF paints a different picture
While the 11.6x P/S ratio points to a rich valuation, the SWS DCF model tells a more cautious story, with a future cash flow value of $32.06 per share compared with the current $44.93 price. On this basis, the stock screens as overvalued using this method. Which signal do you give more weight to?
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Arxis for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 46 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
With mixed signals on valuation and sentiment, it makes sense to check the underlying data yourself, then weigh up the 2 key rewards and 2 important warning signs.
Looking for more investment ideas?
If Arxis has sharpened your focus, do not stop here. Broaden your watchlist today so you are not chasing the next opportunity after it has already moved.
- Target companies that combine value with quality by scanning 46 high quality undervalued stocks that fit your return and risk preferences.
- Strengthen your income stream by reviewing 10 dividend fortresses offering yields that may complement a growth focused portfolio.
- Prioritize resilience by checking 63 resilient stocks with low risk scores designed for investors who care as much about stability as upside.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
